AWM
TAK icon

Axxcess Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Axxcess Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,961
Closed -$152K – 939
2024
Q1 		$152K Hold
10,961
– – ﹤0.01% 837
2023
Q4 		$156K Hold
10,961
– – ﹤0.01% 797
2023
Q3 		$170K Buy
+10,961
New +$170K 0.01% 749

Other funds holding TAK

GAM
Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Axxcess Wealth Management's TAK Position: Q2 2024 in Review

Axxcess Wealth Management sold out of Takeda Pharmaceutical (TAK) in Q2 2024, closing a stake of 10,961 shares — an estimated $152K sold.

Axxcess Wealth Management first reported a position in TAK in Q3 2023 and held it in 3 quarters. The position peaked at $170K in Q3 2023. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2024.

  • Axxcess Wealth Management reported no remaining Takeda Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Axxcess Wealth Management sold 10,961 Takeda Pharmaceutical shares in Q2 2024, an estimated $152K.
  • Axxcess Wealth Management first reported a position in Takeda Pharmaceutical in Q3 2023 and held it in 3 quarters.
  • Axxcess Wealth Management's Takeda Pharmaceutical position peaked at $170K in Q3 2023.
  • 283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2024.

Based on Axxcess Wealth Management's 13F filing for Q2 2024, filed 9 Aug 2024.